References
- SedghGSinghSHussainRIntended and unintended pregnancies worldwide in 2012 and recent trendsStud Fam Plann201445330131425207494
- UNAIDSMiles To Go: Closing Gaps, Breaking Barriers, Righting InjusticesGeneva, SwitzerlandJoint United Nations Programme on HIV/AIDS72018
- ThurmanARClarkMRDoncelGFMultipurpose prevention technologies: Biomedical tools to prevent HIV-1, HSV-2, and unintended pregnanciesInfect Dis Obstet Gynecol20112011110
- AVACMultipurpose Prevention Technolgies (MPTs): An Introductory Factsheet62016 Available from: https://www.avac.org/sites/default/files/resource-files/mpt_product_dev.pdfAccessed January 11, 2018
- FarringtonEMBellDCDibaccoAEReasons people give for using (or not using) condomsAIDS Behav201620122850286226969001
- van der StratenAStadlerJMontgomeryEWomen’s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South AfricaPLoS One201492e8911824586534
- Van der ElstEMMboguaJOperarioDHigh acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PreP in at-risk populations in KenyaAIDS Behav20131762162217223080358
- Young HoltBRomanoJManningJEnsuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approachBJOG: Int J Obstet Gy2014121Suppl38
- BradyMTolleyEAligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologiesBJOG: Int J Obstet Gy2014121Suppl 57078
- BradyMManningJLessons from reproductive health to inform multipurpose prevention technologies: don’t reinvent the wheelAntiviral Res2013100SupplS25S3124188700
- MarrazzoJMRamjeeGRichardsonBAVOICE Study TeamTenofovir-based preexposure prophylaxis for HIV infection among African womenN Engl J Med2015372650951825651245
- LueckeEHChengHWoeberKStated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) studyJ Int AIDS Soc20161912087527247202
- van der StratenAShapley-QuinnMKReddyKFavoring “Peace of Mind”: a qualitative study of African Women’s HIV prevention product formulation preferences from the MTN-020/ASPIRE trialAIDS Patient Care and STDs2017317305314
- van der StratenAAgotKAhmedKThe tablets, ring, injections as options (trio) study: what young African women chose and used for future HIV and pregnancy preventionJ Int AIDS Soc2018213e2509429600595
- WeinribRMinnisAAgotKEnd-users’ product preference across three multipurpose prevention technology delivery forms: baseline results from young Women in Kenya and South AfricaAIDS Behav201822113314529052018
- AVACGlobal PrEP initiation Tracker2018 Available from: URL: https://www.prepwatch.org/wp-content/uploads/2018/07/PW_Global-Tracker_July2018.xlsxAccessed July 20, 2018
- NelAMartinsJBekkerLGSafety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: a phase 1 randomized trialPLoS One2018135e019690429813074
- BaetenJMPalanee-PhillipsTBrownERUse of a vaginal ring containing Dapivirine for HIV-1 prevention in womenN Engl J Med2016375222121213226900902
- BekkerLGLiSTolleyEHPTN 076: TMC278 La safe, tolerable and acceptable for HIV pre-exposure prophylaxisPaper presented at: CROI2017Seattle, WA, USA
- MontgomeryETvan der StratenAChitukutaMMTN-020/ASPIRE StudyAcceptability and use of a dapivirine vaginal ring in a phase III trialAIDS20173181159116728441175
- MenschBSvan der StratenAKatzenLLAcceptability in microbicide and PrEP trials: current status and a reconceptualizationCurr Opin HIV AIDS20127653454123032737
- MinnisAMRobertsSTAgotKTRIO Study TeamYoung women’s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South AfricaAIDS Behav20182282662267329560570
- Delany-MoretlweSMullickSEakleRReesHPlanning for HIV preexposure prophylaxis introduction: lessons learned from contraceptionCurr Opin HIV AIDS2016111879326575146
- RossJHardeeKMumfordEEidSContraceptive method choice in developing countriesInternational Family Planning Perspectives20022813240
- MinnisAMBrowneENBoeriMYoung women’s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South AfricaJ Int AIDS Soc Epub201919
- van der StratenAMontgomeryETChengHHigh acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African womenAIDS Behav20121671775178622644068
- MontgomeryETvan der StratenAChengHVaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect useAIDS Behav20121671787179822790902
- NelABekkerLGBukusiESafety, acceptability and adherence of Dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in sub-Saharan AfricaPLoS One2016113e014774326963505
- van der StratenAMontgomeryETMusaraPDisclosure of pharmacokinetic drug results to understand nonadherenceAIDS201529162161217126544581
- HosekSCelumCWilsonCMKapogiannisBDelany-MoretlweSBekkerLGPreventing HIV among adolescents with oral PreP: observations and challenges in the United States and South AfricaJ Int AIDS Soc2016197(Suppl 6)2110727760684
- MackNEvensEMTolleyEEThe importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative studyJ Int AIDS Soc2014173 Suppl 21915725224616
- BekkerLGGillKWallaceMPre-exposure prophylaxis for South African adolescents: what evidence?S Afr Med J20151051190791126632316
- KrogstadEAAtujunaMMontgomeryETPerspectives of South African youth in the development of an implant for HIV preventionJ Int AIDS Soc2018218e2517030152004
- DehlendorfCKrajewskiCBorreroSContraceptive counseling: best practices to ensure quality communication and enable effective contraceptive useClin Obstet Gynecol201457465967325264697